Pharmaceutical organization engaged in delivering advanced Discovery, Contract Development, and Manufacturing (CDMO) solutions.
This company operates a state-of-the-art manufacturing and R&D facility designed to support complex chemical process development and large-scale production of pharmaceutical intermediates and specialty chemicals.
The plant is equipped with modern pilot and commercial-scale reactors, ranging from 0.5 KL to 3 KL, constructed with stainless steel, glass-lined, and all-glass reactors to handle diverse chemistries. A dedicated hydrogenation facility enables safe and efficient execution of high-pressure reactions.
The facility includes a well-equipped kilo lab and scale-up unit with 50 L to 200 L glass assemblies, supporting seamless transition from laboratory development to pilot-scale manufacturing. Advanced column purification systems allow processing at multi-kilogram levels, ensuring high product purity.
The company maintains an integrated drying unit, ensuring efficient downstream processing and readiness for dispatch. The plant is supported by well-equipped Quality Control laboratories featuring advanced analytical instruments to ensure strict adherence to quality and regulatory standards.
From an environmental and safety standpoint, the site is equipped with double-stage scrubber systems for effective emission control. The facility currently operates with an electrical boiler system, with plans to transition to a CNG-based system to enhance energy efficiency and sustainability.
Overall, the plant is designed to deliver safe, scalable, and compliant manufacturing, supporting the needs of global pharmaceutical and specialty chemical partners.